Explore the full insider trade history of 압타바이오, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 압타바이오 has logged 19 public disclosures. The latest transaction was reported on 28 May 2025 (Other). Among the most active insiders: 이수진. The full history is openly available.
19
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
2 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.